We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.67B
AUM Growth
+$2.26B
Cap. Flow
+$1.95B
Cap. Flow %
20.18%
Top 10 Hldgs %
21.78%
Holding
2,843
New
810
Increased
656
Reduced
567
Closed
731

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$257M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
3
MSFT icon
Microsoft
MSFT
+$247M
4
AER icon
AerCap
AER
+$77.8M
5
ON icon
ON Semiconductor
ON
+$61.6M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Industrials 11.23%
4 Financials 8.63%
5 Healthcare 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOOK
2351
DELISTED
HOOKIPA Pharma
HOOK
-2,206
Closed -$130K
HOPE icon
2352
Hope Bancorp
HOPE
$1.78B
-115,187
Closed -$1.66M
HOUS
2353
DELISTED
Anywhere Real Estate
HOUS
-42,051
Closed -$738K
HPP
2354
Hudson Pacific Properties
HPP
$787M
-3,263
Closed -$600K
HRL icon
2355
Hormel Foods
HRL
$13.1B
-229,916
Closed -$9.43M
HROW icon
2356
Harrow
HROW
$1.54B
-11,147
Closed -$101K
HRTG icon
2357
Heritage Insurance Holdings
HRTG
$1.01B
-29,702
Closed -$202K
HSII
2358
DELISTED
Heidrick & Struggles
HSII
-4,722
Closed -$211K
HSTM icon
2359
HealthStream
HSTM
$844M
-9,158
Closed -$262K
HWC icon
2360
Hancock Whitney
HWC
$6.05B
-20,774
Closed -$979K
IAS
2361
DELISTED
Integral Ad Science
IAS
-29,513
Closed -$609K
IBIO icon
2362
iBio
IBIO
$71M
-73
Closed -$39K
IBN icon
2363
ICICI Bank
IBN
$107B
-15,610
Closed -$295K
ICHR icon
2364
Ichor Holdings
ICHR
$2.25B
-12,838
Closed -$528K
IDXX icon
2365
Idexx Laboratories
IDXX
$43.9B
-25,650
Closed -$16M
IFF icon
2366
International Flavors & Fragrances
IFF
$21.5B
-18,014
Closed -$2.41M
INDB icon
2367
Independent Bank
INDB
$3.97B
-43,593
Closed -$3.32M
INFY icon
2368
Infosys
INFY
$48.4B
-11,236
Closed -$250K
ING icon
2369
ING
ING
$99.5B
-27,319
Closed -$396K
INSW icon
2370
International Seaways
INSW
$4.93B
-15,857
Closed -$289K
INTC icon
2371
Intel
INTC
$476B
-84,548
Closed -$4.5M
IOSP icon
2372
Innospec
IOSP
$2.31B
-10,143
Closed -$854K
IPG
2373
DELISTED
Interpublic Group of Companies
IPG
-34,334
Closed -$1.26M
IPGP icon
2374
IPG Photonics
IPGP
$3.12B
-6,933
Closed -$1.1M
ISRG icon
2375
Intuitive Surgical
ISRG
$134B
-1,845
Closed -$611K

Similar funds

Michael Gelband's Q4 2021 Portfolio in Review

As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.

  • Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
  • Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
  • Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
  • Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
  • Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
  • Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.